In particular, by producing PGE2 either constitutively or upon induction by NK cells, MAFs decrease the expression of two activating NK-receptors, NKp44 and NKp30, at the surface of NK cells, leading to an impairment of the NK cell-mediated killing of melanoma cells. The gene discussed is NCR3; the disease is melanoma.